Post-IPO Debt - Adaptive Biotechnologies - Sep 12, 2022 Funding Round Profile - Cointime

Bitcoin $95,684.19 -1.68%
Ethereum $3,328.96 -1.51%
BNB $658.59 -1.12%
Optimism $1.79 -0.56%
Arbitrum $0.76 -0.55%
Solana $182.91 -1.62%
Polygon $0.48 -0.15%
Cosmos $6.56 -1.85%
Avalanche $37.31 -2.89%

Bitcoin $95,684.19 -1.68%
Ethereum $3,328.96 -1.51%
BNB $658.59 -1.12%
Optimism $1.79 -0.56%
Arbitrum $0.76 -0.55%
Solana $182.91 -1.62%
Polygon $0.48 -0.15%
Cosmos $6.56 -1.85%
Avalanche $37.31 -2.89%

Adaptive Biotechnologies

company

Funding Round

Post-IPO Debt

Money Raised

$ 125M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
OrbiMed	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Mar 24, 2022	Post-IPO Equity	0	ARK Investment Management	Detail
Apr 15, 2014	Series D	$ 100M	Viking Global Investors	Detail
Mar 5, 2018	Secondary Market	0	EquityZen	Detail
Jul 14, 2020	Post-IPO Equity	0		Detail
Sep 13, 2013	Grant	$ 2.50M		Detail
May 7, 2015	Series F	$ 195M	Matrix Capital Management,Rock Springs Capital,etc.	Detail
Apr 7, 2014	Series C	$ 5M	Viking Global Investors	Detail
Jan 7, 2015	Series E	$ 94M		Detail
Jun 10, 2011	Series B	$ 5.80M		Detail
Mar 24, 2010	Series A	$ 4.55M		Detail
Jun 26, 2019	IPO	$ 300M		Detail